PHARMACYTE BIOTECH, INC. Remaining Share Repurchase Authorization
PHARMACYTE BIOTECH, INC. (PMCB) had Remaining Share Repurchase Authorization of $4.68 million as of 2024-04-30, per its 10-K filed 2024-08-13.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 · last filed 2024-08-13
- 2024-04-30: Stock Repurchase Program, Remaining Authorized Repurchase Amount $4.68M.
- 2024-01-31: Stock Repurchase Program, Remaining Authorized Repurchase Amount $5.87M.
- 2023-10-31: Stock Repurchase Program, Remaining Authorized Repurchase Amount $6.27M.
- 2023-07-31: Stock Repurchase Program, Remaining Authorized Repurchase Amount $6.44M.
| Period end | Stock Repurchase Program, Remaining Authorized Repurchase Amount |
|---|---|
| 2024-04-30 | $4.68M 10-K · filed 2024-08-13 |
| 2024-01-31 | $5.87M 10-Q · filed 2024-03-18 |
| 2023-10-31 | $6.27M 10-Q · filed 2023-12-15 |
| 2023-07-31 | $6.44M 10-Q · filed 2023-09-18 |
| 2023-04-30 | $6.50M 10-K · filed 2023-07-31 |
| 2023-01-31 | $10.75M 10-Q · filed 2023-03-16 |
| 2022-10-31 | $4.52M 10-Q · filed 2022-12-14 |
| 2022-07-31 | $7.91M 10-Q · filed 2022-09-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |